Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$425,755
-$67,834 QoQ
Shares Held
8,881
-33.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#762
of 1,348 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $2,738,678 across 11 Drug Manufacturers - General names. NVO ranks #2 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
833 | $999,123 | |
| 2 | NVO |
Novo Nordisk A S
This page
|
8,881 | $425,755 | |
| 3 | ABBV |
AbbVie Inc.
|
1,197 | $301,212 | |
| 4 | PFE |
Pfizer Inc
|
9,522 | $229,288 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,760 | $226,160 | |
| 6 | AMGN |
Amgen Inc
|
597 | $216,185 | |
| 7 | AZN |
Astrazeneca PLC
|
1,049 | $198,911 | |
| 8 | JNJ |
Johnson & Johnson
|
336 | $85,333 |
All Filings in NVO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $425,755 | 8,881 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $493,589 | 13,431 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $346,238 | 6,805 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $382,437 | 6,892 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $327,706 | 4,748 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $543,784 | 7,831 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $519,302 | 6,037 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $645,240 | 5,419 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,613,429 | 46,332 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,925,188 | 30,570 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $782,495 | 7,564 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,576,603 | 28,333 | Shares | Defined | 2023-11-15 | |
| 2023-03-31 | $640,697 | 4,026 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $148,603 | 1,098 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $36,464 | 366 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||